Entering text into the input field will update the search result below

Inovio down on termination of Roche collaboration

Nov. 17, 2014 9:07 AM ETInovio Pharmaceuticals, Inc. (INO) StockBy: Douglas W. House, SA News Editor
  • Inovio Pharmaceuticals (NASDAQ:INO) is off 13% premarket on increased volume in response its announcement of the termination its INO-5150 prostate cancer co-development deal with Roche (OTCQX:RHHBY).
  • The company plans to independently advance INO-5150 into Phase 1 in 1H 2015.

Recommended For You

More Trending News

About INO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
INO--
Inovio Pharmaceuticals, Inc.